Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 – over 90% of them ...
QIAGEN N.V. today announced the launch of the QIAprep& Plasmodium Kit and two companion assays to support malaria research and surveillance efforts. This new solution combines sample preparation ...
A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug ...
Understanding of genetic factors that influence prostate cancer and other conditions is expected to improve thanks to a ...
A new Drosophila collection of Parkinsonism models reveals early synaptic cholinergic projection neuron dysfunction, linking synaptic failure to later dopaminergic decline, highlighting a role for ...
What is the current share price of AMP Limited (AMP)? AMP Limited's (AMP) current share price is $1.28. This constitutes a price movement of 1.19% when compared to the share price 7 days ago and is ...
Malaria remains a major global health threat, with more than 250 million cases and 600,000 deaths in 2024 over 90% of them in Africa QIAprep& Plasmodium Kit enables streamlined detection ...
In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.
We present a technology that offers a photoactivatable RNA base editor for tunable and reversible regulation of gene expression, with implications for improving the safety and efficacy of gene ...
Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the double strand break can result in insertion or deletion mutations, while repair pathways can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback